Solvonis Therapeutics plc (LON:SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.269
-0.021 (-7.24%)
Apr 28, 2026, 4:35 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 19.74 million as of April 28, 2026. Its market cap has increased by 429.06% in one year.
Market Cap
19.74M
Enterprise Value
18.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 19.74M, a decrease of -14.30%. That is a compound annual growth rate of -3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 19.74M | -6.45% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castings P.L.C. | 113.04M |
| IMI plc | 361.04M |
| Associated British Engineering | 819.60K |
| Morgan Advanced Materials | 593.02M |
| Goodwin | 850.09M |
| Bodycote | 1.19B |
| Rotork | 2.68B |
| Spirax Group | 5.43B |